Our website would like to use cookies to store information on your computer. You may delete and block all cookies from this site, but parts of the site will not work as a result. Find out more about how we use cookies.
 IAPO - International Alliance of Patients' Organizations IAPO - International Alliance of Patients' Organizations  
  Feedback   Search   Contact Us   Languages   Sitemap
 
 IAPO - International Alliance of Patients' Organizations   IAPO - A Global Voice for Patients IAPO - A Global Voice for Patients IAPO - A Global Voice for Patients IAPO - A Global Voice for Patients
 IAPO - International Alliance of Patients' Organizations  IAPO Home Page IAPO Alliance IAPO News IAPO Patient Centred Healthcare IAPO Membership IAPO Patients' Exchange IAPO Community
  IAPO - International Alliance of Patients' Organizations
 

 
     
  Login>
Fogotten Password>

 
 
All Content © 2009
Legal Disclaimer


 
 
IAPO's advocacy on NCDs

IAPO has advocated on non-communicable diseases (NCDs) since 2011. NCDs are defined by the World Health Organization (WHO) by four disease areas, cardiovascular disease, cancer, diabetes and chronic respiratory disease). IAPO believes it is essential that patient-centred solutions are found to prevent and manage NCDs globally.

NCDs news - September 2013
Following the adoption of an omnibus resolution on NCDs in May at the 66th World Health Assembly, WHO has developed a draft terms of reference for a global coordination mechanism (GCM) for NCDs. The purpose of the GCM is to improve coordination of activities which address functional gaps that are barriers to the prevention and control of NCDs.

The draft terms of reference have been put out for consultation and IAPO has responded to this consultation. In its response, IAPO highlighted:

  • The need for a sustainable financing mechanism for the GCM
  • The need to ensure that all stakeholders have the opportunity to participate in the GCM
  • That the principles of diversity and equity underpin the GCM

Read IAPO's response in full.

Why does IAPO advocate on NCDs?
Chronic diseases are by far the leading cause of mortality globally, representing over 60% of all deaths. Out of the 36 million people who died from chronic disease in 2008, nine million were under 60 and 80 per cent of these premature deaths occurred in low and middle-income countries.

IAPO’s members are made up predominantly by patient groups who support patients with chronic diseases. Therefore, NCDs is an important area for IAPO to advocate on. Since 2011, IAPO has advocated for strategies to prevent and manage NCDs to be extended to alll chronic diseases.

NCDs - the story so far
As a result of the increasing number of people suffering with chronic disease, the issue has gained attention from the global community. WHO has developed a Global Strategy on NCDs and in September 2011, a United Nations (UN) High-Level Meeting was held on NCDs. IAPO attended this meeting and as well as participating in a roundtable discussion, delivered a statement on NCDs calling for urgent action.

At the High-Level Meeting, a political declaration on NCDs was adopted, which sets out a global mandate for action against NCDs.

Read more about IAPO's advocacy at the UN High-Level Meeting 

Since the High-Level Meeting, WHO has been developing its strategy on NCDs. The first area of this strategy is the Global Action Plan on NCDs (GAP). The GAP sets out the strategy to reduce the overall mortality rate from NCDs. In 2012, the World Health Assembly adopted a target to reduce mortality from NCDs by 25% by 2025. The GAP outlines the strategy towards achieving this target. IAPO has responded to two consultations on this, one in 2012 and another in 2013.

The second area of the NCD strategy is the global monitoring framework (GMF). The GMF sets out the framework for monitoring the progress towards acheiving the 25% target through a set of indicators and targets. IAPO has responded to two WHO consultations on the GMF in April 2012 and October 2012.

The third area is on multisectoral action. This sets outs how WHO will partner with other UN agencies, governments and healthcare stakeholders, including non-governmental organizations (NGOs) to implement the NCD strategy. IAPO has responded to a WHO consultation on multisectoral action.

IAPO's advocacy
At the UN High-Level Meeting on the Prevention and Control of Non-communicable Dieases in September 2011, IAPO published it's Statement on the Prevention and Control of NCDs. In the Statement, IAPO welcomed action to address to address a broad range of NCDs and called on the all stakeholders to involve patients in NCD strategies.

Read IAPO's Statement on the Prevention and Control of NCDs

Since the High-Level Meeting, IAPO has responded to WHO consultations on the NCD strategy and made statements at the World Health Assembly. Read more on the consultations below.

In all of its NCD advocacy work, IAPO outlines:

  • The importance of the full and active participation of patients in all strategies to prevent and manage NCDs
  • That NCDs are a public health issue and are a major socio-economic challenge to development
  • That access to affordable, quality healthcare is essential to managing NCDs

IAPO comments on WHO's Global Action Plan on NCDs (first consultation)

IAPO comments on WHO's Global Action Plan on NCDs (second consultation)

IAPO comments on WHO's discussion paper on multi-sectoral action on NCDs

IAPO comments on WHO's discussion paper on the global monitoring framework (first consultation)

IAPO comments on WHO's discussion paper on the global monitoring framework (second consultation)


 

Attachments...
PDF file
PDF file
PDF file
PDF file
PDF file
PDF file
PrintPrint


Powered by
Powered by Novacaster